CN Patent

CN110437043A — 由白藜芦醇与前列腺素类似物剂构成的共晶及其在制备抗肿瘤药物中的用途

Assigned to Individual · Expires 2019-11-12 · 7y expired

What this patent protects

本发明提供了一种由白藜芦醇与前列腺素类似物构成的共晶复合物以及含有该共晶复合物的药物组合物，其特征在于，所述前列腺素类似物是选自拉坦前列素、曲伏前列素、贝美前列素、他氟前列素与Latanoprostene Bunod中的一种。本发明所述的共晶复合物可对肺癌、胃癌等多种癌细胞的细胞增殖产生协同的抑制作用(CI<1)。

USPTO Abstract

本发明提供了一种由白藜芦醇与前列腺素类似物构成的共晶复合物以及含有该共晶复合物的药物组合物，其特征在于，所述前列腺素类似物是选自拉坦前列素、曲伏前列素、贝美前列素、他氟前列素与Latanoprostene Bunod中的一种。本发明所述的共晶复合物可对肺癌、胃癌等多种癌细胞的细胞增殖产生协同的抑制作用(CI<1)。

Drugs covered by this patent

Patent Metadata

Patent number
CN110437043A
Jurisdiction
CN
Classification
—
Expires
2019-11-12
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.